Parsley-Derived Exosomes Cut Inflammation and Preserve Muscle in Aging Study
A Tokyo startup uses plant exosomes from parsley to fight aging, showing reduced inflammation and preserved muscle strength in mice and a small human pilot.
Summary
TIME TRAVELER, a Tokyo biotech and XPRIZE Healthspan finalist, is testing exosomes extracted from parsley as a longevity supplement. Exosomes are tiny vesicles cells release that carry enzymes, fats, and genetic material. The team screened over 140 edible plants and algae before identifying parsley as the top performer. In mice, parsley-derived exosomes reduced inflammatory markers tied to cellular aging and helped animals retain muscle strength longer than untreated peers. A small 40-person human pilot showed similar anti-inflammatory effects plus anecdotal improvements in sleep and energy. The company will now advance to a larger XPRIZE trial measuring muscle function, walking speed, leg strength, cognitive performance, and inflammatory blood markers — a rigorous test that could validate plant-based exosomes as a practical, scalable alternative to animal-derived longevity biologics.
Detailed Summary
Plant-based exosomes are emerging as a potentially safer and more scalable alternative to human or animal-derived versions in longevity medicine, and a Tokyo startup called TIME TRAVELER is among the first to put that idea to a serious scientific test. The company is one of ten global finalists in the $101 million XPRIZE Healthspan competition, which evaluates interventions targeting the biology of aging across muscle, cognition, and inflammatory health.
The core idea originated with tumor biologist Tetsu Akiyama of the University of Tokyo and was developed by co-CEO Tomoatsu Hayashi, who screened more than 140 edible plant and algae species — covering roughly 95% of species cultivated in Japan — looking for plant exosomes that functionally mimic human-derived ones. The surprising winner was parsley. In mouse studies, parsley-derived exosomes administered through drinking water reduced inflammatory markers associated with cellular aging and preserved grip strength and muscle endurance compared to untreated aged mice, measured by standard wire-hang tests used in aging research.
A small human pilot involving 40 participants taking a daily supplement capsule produced encouraging signals: lower inflammatory biomarkers alongside self-reported improvements in sleep consistency and daytime energy. While anecdotal reports carry limited weight, the convergence with the animal data was sufficient for the team to advance in the XPRIZE competition.
The next phase will involve a larger, more rigorous trial assessing muscle function, walking capacity, leg strength, cognitive performance, and inflammatory blood markers — the kinds of functional endpoints that matter for healthspan, not just lifespan.
Key caveats apply. The human data so far is small, uncontrolled, and partly self-reported. Mechanism questions remain open: exactly how plant exosomes interact with human cells at the molecular level is not yet fully characterized. Still, if validated, a food-derived, plant-based exosome supplement would sidestep the regulatory and safety burdens tied to human or animal tissue sourcing — a meaningful practical advantage for scaling any future therapy.
Key Findings
- Parsley-derived exosomes reduced aging-related inflammatory markers in both aged mice and a small human pilot of 40 adults.
- Aged mice receiving parsley exosomes in drinking water retained significantly more grip strength than untreated controls.
- Screening of 140+ edible plant and algae species identified parsley as the top source of human-mimicking exosomes.
- Human pilot participants reported improved sleep consistency and daytime energy alongside measured anti-inflammatory effects.
- TIME TRAVELER will advance to a larger XPRIZE trial measuring muscle function, walking speed, cognition, and inflammatory biomarkers.
Methodology
This is a news profile article from Longevity.Technology covering a competition finalist, not a peer-reviewed research paper. Evidence cited includes unpublished or early-stage mouse studies and a small 40-person uncontrolled human pilot; no primary journal citations are provided in the excerpt. Credibility rests on the team's University of Tokyo affiliation and XPRIZE Healthspan selection, which implies external scientific review.
Study Limitations
Human data is limited to 40 participants in an apparently uncontrolled pilot with self-reported endpoints, making causal inference premature. The article does not reference published peer-reviewed papers for the core findings, limiting independent verification. The molecular mechanism by which plant exosomes affect human cells has not been fully characterized and warrants scrutiny in future studies.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: